ArticleFrontiers in oncology2024

Efficacy of anti-PD-1 monotherapy for recurrent or metastatic olfactory neuroblastoma.

Yuta Hoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.